Detalles de la búsqueda
1.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet;
402(10404): 775-785, 2023 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516125
2.
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
J Headache Pain;
25(1): 35, 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462625
3.
Phase Ib, open-label, fixed-sequence, drug-drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine.
Headache;
63(3): 322-332, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36602199
4.
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.
Lancet Neurol;
23(4): 382-392, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364831
5.
A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches.
Adv Ther;
41(6): 2435-2445, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704799
Resultados
1 -
5
de 5
1
Próxima >
>>